Tarsus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.About TARS
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis.
CEOBobak Azamian
CEOBobak Azamian
Employees244
Employees244
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2017
Founded2017
Employees244
Employees244
TARS Key Statistics
Market cap1.99B
Market cap1.99B
Price-Earnings ratio-13.98
Price-Earnings ratio-13.98
Dividend yield—
Dividend yield—
Average volume447.41K
Average volume447.41K
High today$54.28
High today$54.28
Low today$51.35
Low today$51.35
Open price$53.32
Open price$53.32
Volume327.15K
Volume327.15K
52 Week high$57.28
52 Week high$57.28
52 Week low$20.08
52 Week low$20.08
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%